tiprankstipranks
Fusen Pharmaceutical Co., Ltd. (HK:1652)
:1652
Hong Kong Market
1652
Fusen Pharmaceutical Co., Ltd.
RESEARCH TOOLSreports
Want to see HK:1652 full AI Analyst Report?

Fusen Pharmaceutical Co., Ltd. (1652) Ratios

0 Followers

Fusen Pharmaceutical Co., Ltd. Ratios

HK:1652's free cash flow for Q4 2025 was ¥0.41. For the 2025 fiscal year, HK:1652's free cash flow was decreased by ¥ and operating cash flow was ¥0.07. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.56 0.56 0.60 0.85 0.85
Quick Ratio
 0.45 0.45 0.42 0.58 0.70
Cash Ratio
 0.10 0.10 0.03 0.05 0.18
Solvency Ratio
 0.02 0.03 -0.18 >-0.01 >-0.01
Operating Cash Flow Ratio
 0.14 0.14 0.17 -0.11 0.15
Short-Term Operating Cash Flow Coverage
 0.39 0.38 0.44 -0.31 0.48
Net Current Asset Value
¥ -396.11M¥ -396.11M¥ -410.19M¥ -214.72M¥ -123.32M
Leverage Ratios
Debt-to-Assets Ratio
 0.26 0.26 0.31 0.26 0.17
Debt-to-Equity Ratio
 0.90 0.90 1.04 0.61 0.37
Debt-to-Capital Ratio
 0.47 0.47 0.51 0.38 0.27
Long-Term Debt-to-Capital Ratio
 0.02 0.02 0.18 0.16 0.00
Financial Leverage Ratio
 3.52 3.52 3.35 2.38 2.20
Debt Service Coverage Ratio
 0.05 0.06 -0.12 0.05 0.19
Interest Coverage Ratio
 -0.09 -0.09 -3.58 1.59 1.27
Debt to Market Cap
 0.45 0.61 0.69 0.38 0.24
Interest Debt Per Share
 0.43 0.47 0.54 0.49 0.32
Net Debt to EBITDA
 10.62 9.41 -9.28 16.33 2.01
Profitability Margins
Gross Profit Margin
40.16%40.16%49.88%52.95%45.76%
EBIT Margin
-3.34%-3.34%-20.60%-2.98%-3.78%
EBITDA Margin
8.29%9.35%-11.98%3.35%10.15%
Operating Profit Margin
-0.63%-0.63%-20.71%3.54%3.20%
Pretax Profit Margin
-2.78%-2.78%-58.41%-5.21%-6.30%
Net Profit Margin
-4.31%-4.31%-57.90%-6.41%-7.05%
Continuous Operations Profit Margin
-4.32%-4.32%-57.91%-6.42%-7.05%
Net Income Per EBT
154.99%154.99%99.13%123.19%111.81%
EBT Per EBIT
441.78%441.78%282.10%-147.12%-196.93%
Return on Assets (ROA)
-0.93%-0.93%-15.25%-2.70%-2.57%
Return on Equity (ROE)
-3.34%-3.28%-51.07%-6.44%-5.64%
Return on Capital Employed (ROCE)
-0.44%-0.44%-14.50%2.95%2.51%
Return on Invested Capital (ROIC)
-0.24%-0.24%-8.69%2.18%1.83%
Return on Tangible Assets
-0.95%-0.95%-15.60%-2.75%-3.05%
Earnings Yield
-1.50%-2.22%-33.95%-4.03%-3.63%
Efficiency Ratios
Receivables Turnover
 2.24 2.24 2.86 3.08 1.99
Payables Turnover
 1.31 1.31 1.32 1.59 1.63
Inventory Turnover
 1.67 1.67 1.19 1.44 2.41
Fixed Asset Turnover
 0.50 0.50 0.52 1.01 1.56
Asset Turnover
 0.22 0.22 0.26 0.42 0.36
Working Capital Turnover Ratio
 -0.76 -0.79 -1.59 -5.50 -11.17
Cash Conversion Cycle
 102.35 102.35 157.91 141.25 111.00
Days of Sales Outstanding
 162.91 162.91 127.49 118.41 183.47
Days of Inventory Outstanding
 218.90 218.90 306.23 252.66 151.41
Days of Payables Outstanding
 279.46 279.46 275.81 229.81 223.89
Operating Cycle
 381.81 381.81 433.72 371.06 334.88
Cash Flow Ratios
Operating Cash Flow Per Share
 0.15 0.16 0.18 -0.10 0.15
Free Cash Flow Per Share
 0.07 0.09 0.08 -0.22 0.11
CapEx Per Share
 0.06 0.07 0.10 0.12 0.03
Free Cash Flow to Operating Cash Flow
 0.48 0.57 0.43 2.21 0.78
Dividend Paid and CapEx Coverage Ratio
 2.52 2.35 1.75 -0.83 3.58
Capital Expenditure Coverage Ratio
 2.52 2.35 1.75 -0.83 4.63
Operating Cash Flow Coverage Ratio
 0.38 0.38 0.35 -0.21 0.48
Operating Cash Flow to Sales Ratio
 0.45 0.45 0.41 -0.13 0.22
Free Cash Flow Yield
8.18%13.17%10.33%-17.97%9.07%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -66.59 -45.08 -2.95 -24.83 -27.55
Price-to-Sales (P/S) Ratio
 2.63 1.94 1.71 1.59 1.94
Price-to-Book (P/B) Ratio
 2.18 1.48 1.50 1.60 1.55
Price-to-Free Cash Flow (P/FCF) Ratio
 12.22 7.59 9.68 -5.56 11.02
Price-to-Operating Cash Flow Ratio
 6.35 4.36 4.16 -12.28 8.64
Price-to-Earnings Growth (PEG) Ratio
 -0.61 0.48 >-0.01 -2.71 0.08
Price-to-Fair Value
 2.18 1.48 1.50 1.60 1.55
Enterprise Value Multiple
 42.34 30.20 -23.51 63.91 21.14
Enterprise Value
 959.02M 771.71M 918.63M 1.21B 1.05B
EV to EBITDA
 42.34 30.20 -23.51 63.91 21.14
EV to Sales
 3.51 2.82 2.82 2.14 2.15
EV to Free Cash Flow
 16.31 11.03 16.00 -7.48 12.18
EV to Operating Cash Flow
 7.76 6.33 6.87 -16.50 9.55
Tangible Book Value Per Share
 0.43 0.47 0.46 0.74 0.53
Shareholders’ Equity Per Share
 0.45 0.49 0.50 0.78 0.81
Tax and Other Ratios
Effective Tax Rate
 -0.55 -0.55 <0.01 -0.23 -0.12
Revenue Per Share
 0.34 0.37 0.44 0.78 0.65
Net Income Per Share
 -0.01 -0.02 -0.26 -0.05 -0.05
Tax Burden
 1.55 1.55 0.99 1.23 1.12
Interest Burden
 0.83 0.83 2.84 1.75 1.67
Research & Development to Revenue
 0.06 0.05 0.33 0.14 0.03
SG&A to Revenue
 0.39 0.39 0.43 0.13 0.14
Stock-Based Compensation to Revenue
 0.00 0.00 <0.01 <0.01 <0.01
Income Quality
 -304.79 -10.62 -0.70 2.49 -3.56
Currency in CNY